VKH
HAE icon

Virtu KCG Holdings’s Haemonetics HAE Stock Holding History

Virtu KCG Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,430
Closed -$269K – 3556
2016
Q3 		$269K Buy
+7,430
New +$255K 0.01% 2040
2015
Q3 		– Sell
-8,533
Closed -$353K – 3520
2015
Q2 		$353K Buy
+8,533
New +$360K 0.01% 1863
2015
Q1 		– Sell
-9,251
Closed -$346K – 3421
2014
Q4 		$346K Buy
+9,251
New +$339K 0.01% 2165
2013
Q4 		– Sell
-6,681
Closed -$266K – 3956
2013
Q3 		$266K Buy
+6,681
New +$280K ﹤0.01% 2767

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virtu KCG Holdings's HAE Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Haemonetics (HAE) in Q4 2016, closing a stake of 7,430 shares — an estimated $269K sold.

Virtu KCG Holdings first reported a position in HAE in Q3 2013 and held it in 4 quarters. The position peaked at $353K in Q2 2015. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Haemonetics position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 7,430 Haemonetics shares in Q4 2016, an estimated $269K.
  • Virtu KCG Holdings first reported a position in Haemonetics in Q3 2013 and held it in 4 quarters.
  • Virtu KCG Holdings's Haemonetics position peaked at $353K in Q2 2015.
  • 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.